Replimune 集團有限公司
US ˙ NasdaqGS ˙ US76029N1063

簡介

本頁面提供了有關 Paolo Pucci 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Paolo Pucci已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:WST / West Pharmaceutical Services, Inc. Director 11,854
US:REPL / Replimune Group, Inc. Director 16,500
US:TRIL / Tidal Trust II - Defiance Trillion Dollar Club Index ETF Director 0
US:MRUS / Merus N.V. Director 6,120
US:ARQL / ArQule, Inc. Chief Executive Officer, Director 0
Director 27,777
US:DYAX / Dyax Corp. 0
如何解讀這些圖表

以下圖表顯示了在Paolo Pucci進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

REPL / Replimune Group, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 REPL / Replimune Group, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

REPL / Replimune Group, Inc. Insider Trades
REPL / Replimune Group, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 REPL / Replimune Group, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

REPL / Replimune Group, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Paolo Pucci 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-06 2026-05-04 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 791 11,854 7.15
2025-05-08 2025-05-06 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1,071 10,947 10.84
2024-04-25 2024-04-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 564 9,876 6.06
2023-04-27 2023-04-25 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 616 9,312 7.08
2022-05-26 2022-05-24 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 632 8,696 7.84
2022-04-05 2022-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16,500 16,500
2021-11-19 2021-11-17 4 TRIL Trillium Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -67,000 0 -100.00
2021-06-02 2021-05-28 4 MRUS Merus N.V.
Share option (right to buy)
A - Award 6,120 6,120
2021-05-06 2021-05-04 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 577 8,064 7.71
2021-04-05 2021-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16,500 16,500
2020-07-02 2020-06-30 4 MRUS Merus N.V.
Share Option (right to buy)
A - Award 17,262 17,262
2020-05-07 2020-05-05 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 975 7,470 15.01
2020-04-02 2020-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 33,000 33,000
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -305,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -285,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -7,578 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -14,925 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -100,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -650,850 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -150,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -80,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -249,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -600,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -300,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -120,000 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -242,502 0 -100.00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Common Stock
U - Other -1,235,782 0 -100.00 20.00 -24,715,640
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Stock Options (Right to Buy)
M - Exercise -360,000 0 -100.00
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Stock Options (Right to Buy)
M - Exercise -285,075 0 -100.00
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Stock Options (Right to Buy)
M - Exercise -302,422 0 -100.00
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Stock Options (Right to Buy)
M - Exercise -225,000 0 -100.00
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Common Stock
F - Taxes -646,639 1,235,245 -34.36 20.11 -13,003,910 24,840,777
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Common Stock
M - Exercise 360,000 1,881,884 23.65 1.79 644,400 3,368,572
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Common Stock
M - Exercise 285,075 1,521,884 23.05 6.70 1,910,002 10,196,623
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Common Stock
M - Exercise 302,422 1,236,809 32.37 7.95 2,404,255 9,832,632
2019-12-20 2019-12-18 4 ARQL ARQULE INC
Common Stock
M - Exercise 225,000 934,387 31.72 3.42 769,500 3,195,604
2019-09-12 2019-09-11 4 ARQL ARQULE INC
Employee Stock Option (Right to Buy)
M - Exercise -5,000 7,578 -39.75
2019-09-12 2019-09-11 4 ARQL ARQULE INC
Common Stock
M - Exercise 5,000 707,417 0.71 7.95 39,750 5,623,965
2019-05-09 2019-05-07 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1,565 6,367 32.59
2019-03-18 2019-03-15 4 ARQL ARQULE INC
Employee Stock Option (Right to Buy)
M - Exercise -50,000 242,502 -17.09
2019-03-18 2019-03-15 4 ARQL ARQULE INC
Common Stock
M - Exercise 50,000 618,208 8.80 1.16 58,000 717,121
2019-03-14 2019-03-12 4 ARQL ARQULE INC
Employee Stock Options
A - Award 300,000 300,000
2019-01-17 2019-01-15 4 ARQL ARQULE INC
Employee Stock Options
A - Award 650,850 650,850
2018-07-25 2018-07-23 4 ARQL ARQULE INC
Employee Stock Options
A - Award 150,000 150,000
2018-06-11 2018-06-08 4 ARQL ARQULE INC
Stock Option (Right to Buy)
M - Exercise -398,736 0 -100.00
2018-06-11 2018-06-08 4 ARQL ARQULE INC
Stock Options (Right to Buy)
M - Exercise -101,264 0 -100.00
2018-06-11 2018-06-08 4 ARQL ARQULE INC
Common Stock
F - Taxes -352,286 568,208 -38.27 5.78 -2,036,213 3,284,242
2018-06-11 2018-06-08 4 ARQL ARQULE INC
Common Stock
M - Exercise 398,736 920,494 76.42 3.95 1,575,007 3,635,951
2018-06-11 2018-06-08 4 ARQL ARQULE INC
Common Stock
M - Exercise 101,264 521,758 24.08 3.95 399,993 2,060,944
2018-05-25 2018-05-23 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 27,777 27,777
2018-05-18 2018-05-18 4 ARQL ARQULE INC
Common Stock
P - Purchase 15,000 420,494 3.70 3.39 50,848 1,425,433
2018-05-11 2018-05-10 4 ARQL ARQULE INC
Common Stock
P - Purchase 1,300 405,494 0.32 2.64 3,427 1,068,963
2018-05-11 2018-05-08 4 ARQL ARQULE INC
Employee Stock Options
A - Award 80,000 80,000
2018-05-10 2018-01-16 4 ARQL ARQULE INC
Employee Stock Options
A - Award 249,000 249,000
2018-05-03 2018-05-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1,824 4,802 61.25
2017-09-08 2017-09-07 4 ARQL ARQULE INC
Common Stock
P - Purchase 1,101 404,194 0.27 1.15 1,261 462,964
2017-09-07 2017-09-06 4 ARQL ARQULE INC
Common Stock
P - Purchase 16,397 403,093 4.24 1.15 18,840 463,154
2017-09-06 2017-09-05 4 ARQL ARQULE INC
Common Stock
P - Purchase 19,156 386,696 5.21 1.14 21,844 440,949
2017-08-31 2017-08-29 4 arql ARQULE INC
Common Stock
P - Purchase 300 367,540 0.08 1.05 315 385,917
2017-08-29 2017-08-28 4 ARQL ARQULE INC
Common Stock
P - Purchase 2,970 367,240 0.82 1.05 3,115 385,198
2017-08-28 2017-08-25 4 ARQL ARQULE INC
Common Stock
P - Purchase 701 364,270 0.19 1.05 736 382,338
2017-08-28 2017-08-24 4 ARQL ARQULE INC
Common Stock
P - Purchase 8,791 363,569 2.48 1.05 9,212 380,984
2017-05-16 2017-05-12 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 13,309 13,309
2017-05-03 2017-05-02 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1,697 2,978 132.46
2017-01-18 2017-01-17 4 ARQL ARQULE INC
Employee Stock Options
A - Award 300,000 300,000
2016-10-04 2016-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 56 56 74.12 4,153 4,153
2016-09-13 2016-09-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1,277 1,277
2016-08-11 2016-08-09 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 4,783 4,783
2016-08-11 2016-08-09 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 17,773 17,773
2016-03-04 2016-03-03 4 ARQL ARQULE INC
Employee Stock Option (Right to Buy)
M - Exercise -97,498 292,502 -25.00
2016-03-04 2016-03-03 4 ARQL ARQULE INC
Common Stock
M - Exercise 97,498 354,778 37.90 1.16 113,098 411,542
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Stock Option (right to buy)
D - Sale to Issuer -50,000 0 -100.00
2016-01-22 2016-01-22 4 DYAX DYAX CORP
Common Stock
D - Sale to Issuer -80,000 0 -100.00
2016-01-20 2016-01-19 4 ARQL ARQULE INC
Employee Stock Options
A - Award 480,000 480,000
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -75,000 0 -100.00
2016-01-15 2016-01-13 4 DYAX DYAX CORP
Common Stock
M - Exercise 75,000 80,000 1,500.00 1.51 113,250 120,800
2015-12-16 2015-12-15 4 ARQL ARQULE INC
Common Stock
P - Purchase 1,283 257,280 0.50 2.16 2,771 555,725
2015-12-14 2015-12-11 4 ARQL ARQULE INC
Common Stock
P - Purchase 1,108 255,997 0.43 2.10 2,324 536,903
2015-12-11 2015-12-10 4 ARQL ARQULE INC
Common Stock
P - Purchase 6,600 254,889 2.66 2.10 13,844 534,655
2015-12-11 2015-12-09 4 ARQL ARQULE INC
Common Stock
P - Purchase 1,009 248,289 0.41 2.10 2,119 521,407
2015-11-16 3 (NLNK) NEWLINK GENETICS CORP
Common Stock
12,340
2015-11-16 3 (NLNK) NEWLINK GENETICS CORP
Common Stock
12,340
2015-05-14 2015-05-12 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 50,000 50,000
2015-01-21 2015-01-20 4 ARQL ARQULE INC
Employee Stock Options
A - Award 390,000 390,000
2014-11-20 2014-11-20 4 ARQL ARQULE INC
Common Stock
P - Purchase 5,000 247,280 2.06 1.26 6,298 311,474
2014-09-05 2014-09-04 4 arql ARQULE INC
Common Stock
P - Purchase 5,000 242,280 2.11 1.30 6,525 316,175
2014-05-27 2014-05-23 4 ARQL ARQULE INC
Common Stock
P - Purchase 5,000 237,280 2.15 1.40 7,010 332,690
2014-05-21 2014-05-20 4 ARQL ARQULE INC
Common Stock
P - Purchase 5,000 232,280 2.20 1.42 7,124 330,929
2014-03-14 2014-03-13 4 ARQL ARQULE INC
Common Stock
P - Purchase 10,000 227,280 4.60 2.10 20,990 477,061
2014-03-06 2014-03-05 4 DYAX DYAX CORP
Stock Option (right to buy)
M - Exercise -25,000 0 -100.00
2014-03-06 2014-03-05 4 DYAX DYAX CORP
Common Stock
S - Sale -20,000 5,000 -80.00 10.31 -206,264 51,566
2014-03-06 2014-03-05 4 DYAX DYAX CORP
Common Stock
M - Exercise 25,000 25,000 1.35 33,750 33,750
2014-01-24 2014-01-22 4 ARQL ARQULE INC
Employee Stock Options
A - Award 305,000 305,000
2013-01-15 2013-01-14 4 ARQL ARQULE INC
Employee Stock Options
A - Award 285,000 1,725,000 19.79
2012-06-07 2012-06-06 4 ARQL ARQULE INC
Common Stock
P - Purchase 4,754 217,280 2.24 6.24 29,684 1,356,718
2012-05-11 2012-05-09 4 DYAX DYAX CORP
Stock Option (right to buy)
A - Award 75,000 75,000
2012-02-03 2012-02-01 4 ARQL ARQULE INC
Employee Stock Options
A - Award 315,000 1,440,000 28.00
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)